Tracing the origins of chromosomal translocations in prostate cancer
追踪前列腺癌染色体易位的起源
基本信息
- 批准号:8531687
- 负责人:
- 金额:$ 11.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos Untranslated RegionsAffectAirAndrogen ReceptorAndrogensAntibodiesArchitectureBindingBiological AssayCarcinomaCell Cycle ProgressionCell LineCellsChIP-seqChromatinChromosomal translocationCoculture TechniquesDNADNA Double Strand BreakDNA Sequence RearrangementDataData SetDevelopmentERG geneETS Family GeneEnzyme ActivationEtiologyFutureGene Expression ProfilingGene Expression RegulationGene FusionGenesGenomeGenomicsGoalsHematologic NeoplasmsHumanHuman GenomeInflammationLNCaPLeadLentivirus VectorLightLinkMalignant NeoplasmsMalignant neoplasm of prostateMediatingMentorsMethodologyModelingMusMutateMutationNF-kappa BNoiseOncogene ActivationOperative Surgical ProceduresPSA screeningPathway interactionsPatientsPhasePhosphorylationPrevalenceProstateProstaticPublicationsRecurrenceRegulationResourcesRoleSignal TransductionSoft Tissue NeoplasmsSpecificitySuggestionTMPRSS2 geneTechnologyTestingTissue MicroarrayTissuesUp-Regulationactivation-induced cytidine deaminasebasecareercell typecohortgenome sequencinggenome-wideimprovedin vivoleukemia/lymphomamacrophagenext generation sequencingnovelp65research studysarcomaskillstranscriptome sequencingtumor progression
项目摘要
DESCRIPTION (provided by applicant): Chromosomal translocations are a hallmark of cancer progression. These translocations often result in gene fusions, a common mechanism for oncogene activation. Until recently, recurrent gene fusions were predominantly associated with hematological malignancies (leukemias and lymphomas) and soft tissue tumors (sarcomas), but were rarely linked to common epithelial carcinomas. This view changed with the discovery of recurrent gene fusions involving ETS family genes in prostate cancer. Among the ETS family gene fusions, the TMPRSS2-ERG fusions involving the 5'untranslated region of androgen-regulated gene TMPRSS2 with the ERG gene are the most common and found in approximately 50% of prostate cancers. The development of next generation sequencing based approaches like RNA-Seq and paired-end whole-genome sequencing have accelerated the discoveries of gene fusions in prostate cancer. However, the mechanisms underlying the formation and cell type specificities of chromosomal translocations are far from clear. Our proposal aims to bridge the gap between the rapid discovery of chromosomal translocations and our limited understanding of the mechanisms leading to their formation. In our recent study, we demonstrate that androgen signaling induces chromosomal proximity between TMPRSS2 and ERG loci, and facilitates the formation of the TMPRSS2-ERG gene fusion when subjected to an agent that causes DNA double strand breaks. These results provide a conceptual framework for the genesis of gene fusions in human prostate cancer. In specific aim 1, we propose to employ next-generation sequencing to identify genome-wide chromosomal interactions mediated by androgen signaling. The mentor's expertise in throughput technologies will help the candidate acquire the necessary skill-set to accomplish aim 1. Interestingly, we identified novel recurrent mutations in the androgen receptor AR collaborating factor FOXA1, which is mutated in 5 of 147 (3.4%) prostate cancers. Preliminary functional studies on one representative mutation revealed that mutated FOXA1 disrupts androgen signaling and increases proliferation. In specific aim 2, we propose to study the effect of FOXA1 mutations in regulating AR signaling and interactome. Aim 2, a logical extension of aim 1 will be pursued during the independent phase (R00). Accomplishment of these two aims will provide us with a comprehensive understanding of the three dimensional genomic architecture of prostatic cells, how AR regulates this architecture, the influence mutations in AR collaborating factors, and importantly how this impacts the formation of gene fusions. While spatial proximity is necessary for chromosomal translocations, it is not sufficient. DNA breaks synergize with spatial proximity to fuel chromosomal translocations. In specific aim 3, we will study the role of inflammation mediated activation of NF-kB pathway in the formation of DNA breaks and ETS gene fusions in prostate cancer. Successful completion of the aims outlined in this proposal will improve our understanding of the origins of chromosomal translocations in prostate cancer, may have broader implications for understanding and treating cancer and may provide suggestions as to the general etiology of human prostate cancer. These projects have been conceived based on my original ideas. Dr. Chinnaiyan has extended his full support towards my career goals and has encouraged me to take these projects to my independent lab in the future.
描述(由申请人提供):染色体易位是癌症进展的标志。这些易位通常导致基因融合,这是癌基因激活的常见机制。直到最近,复发性基因融合主要与血液恶性肿瘤(白血病和淋巴瘤)和软组织肿瘤(肉瘤)有关,但很少与常见的上皮癌有关。这种观点随着前列腺癌中涉及ETS家族基因的复发性基因融合的发现而改变。在ETS家族基因融合体中,涉及雄激素调节基因TMPRSS 2的5 '非翻译区与ERG基因的TMPRSS 2-ERG融合体是最常见的,并且在大约50%的前列腺癌中发现。下一代基于测序的方法如RNA-Seq和配对末端全基因组测序的发展加速了前列腺癌中基因融合的发现。然而,染色体易位的形成和细胞类型特异性的机制还远不清楚。我们的建议旨在弥合染色体易位的快速发现和我们对导致其形成的机制的有限理解之间的差距。在我们最近的研究中,我们证明,雄激素信号诱导TMPRSS 2和ERG基因座之间的染色体接近,并促进TMPRSS 2-ERG基因融合的形成时,受到的代理,导致DNA双链断裂。这些结果提供了一个概念框架的基因融合在人类前列腺癌的起源。在具体目标1中,我们建议采用下一代测序来鉴定由雄激素信号传导介导的全基因组染色体相互作用。导师在生产技术方面的专业知识将帮助候选人获得必要的技能,以实现目标1。有趣的是,我们在雄激素受体AR协作因子FOXA 1中发现了新的复发性突变,该因子在147例前列腺癌中有5例(3.4%)发生突变。对一个代表性突变的初步功能研究显示,突变的FOXA 1破坏雄激素信号传导并增加增殖。在具体目标2中,我们建议研究FOXA 1突变在调节AR信号传导和相互作用组中的作用。目标2是目标1的逻辑延伸,将在独立阶段(R 00)进行。这两个目标的实现将使我们全面了解前列腺细胞的三维基因组结构,AR如何调节这种结构,AR协作因子中的影响突变,以及重要的是如何影响基因融合的形成。虽然空间接近对于染色体易位是必要的,但这是不够的。DNA断裂与空间邻近协同作用以促进染色体易位。在具体目标3中,我们将研究炎症介导的NF-κ B通路活化在前列腺癌中DNA断裂和ETS基因融合形成中的作用。成功完成本提案中概述的目标将提高我们对前列腺癌染色体易位起源的理解,可能对理解和治疗癌症具有更广泛的意义,并可能为人类前列腺癌的一般病因学提供建议。这些项目是根据我的原始想法构思的。Chinnaiyan博士对我的职业目标给予了全力支持,并鼓励我将来将这些项目带到我的独立实验室。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The emerging role of speckle-type POZ protein (SPOP) in cancer development.
- DOI:10.1016/j.drudis.2014.07.009
- 发表时间:2014-09
- 期刊:
- 影响因子:7.4
- 作者:Mani, Ram-Shankar
- 通讯作者:Mani, Ram-Shankar
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ram Shankar Mani其他文献
Ram Shankar Mani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ram Shankar Mani', 18)}}的其他基金
3D genome architecture and the origins of recurrent genomic rearrangements in prostate cancer
3D 基因组结构和前列腺癌中反复基因组重排的起源
- 批准号:
10553609 - 财政年份:2020
- 资助金额:
$ 11.48万 - 项目类别:
3D genome architecture and the origins of recurrent genomic rearrangements in prostate cancer
3D 基因组结构和前列腺癌中反复基因组重排的起源
- 批准号:
10092128 - 财政年份:2020
- 资助金额:
$ 11.48万 - 项目类别:
3D genome architecture and the origins of recurrent genomic rearrangements in prostate cancer
3D 基因组结构和前列腺癌中反复基因组重排的起源
- 批准号:
10328936 - 财政年份:2020
- 资助金额:
$ 11.48万 - 项目类别:
Tracing the origins of chromosomal translocations in prostate cancer
追踪前列腺癌染色体易位的起源
- 批准号:
9204816 - 财政年份:2012
- 资助金额:
$ 11.48万 - 项目类别:
Tracing the origins of chromosomal translocations in prostate cancer
追踪前列腺癌染色体易位的起源
- 批准号:
9045579 - 财政年份:2012
- 资助金额:
$ 11.48万 - 项目类别:
Tracing the origins of chromosomal translocations in prostate cancer
追踪前列腺癌染色体易位的起源
- 批准号:
8374150 - 财政年份:2012
- 资助金额:
$ 11.48万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 11.48万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 11.48万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 11.48万 - 项目类别:
Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10019570 - 财政年份:2019
- 资助金额:
$ 11.48万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10223370 - 财政年份:2019
- 资助金额:
$ 11.48万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10455108 - 财政年份:2019
- 资助金额:
$ 11.48万 - 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 11.48万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 11.48万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 11.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 11.48万 - 项目类别: